Anthem Biosciences Limited — Board Meeting, 05-02-2026: Outcome of Board Meeting
05-02-2026 | 01:16 pm
05-02-2026 | 01:16 pm
Anthem Biosciences' board approved Q3 & 9M consolidated financial results. Q3 revenue hit ₹423.15 Cr, profit stood at ₹92.82 Cr, including a ₹25.37 Cr exceptional provision. Also approved allotment of 1,03,800 ESOP shares.
No comments yet. Be the first to comment!
